Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT)

International Journal of Epidemiology

Volumn 27, Issue 4, 1998, Pages 636-641

  Vaccaro, Olga ^a   Stamler, Jeremiah ^b   Neaton, James D ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Mortality; Risk factors

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE;

EID: 0031657725     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.4.636     Document Type: Article

References (36)

1. West KM. Epidemiology of Diabetes Mellitus and its Vascular Lesions. New York, NY: Elsevier; 1978.
2. Panzram G. Mortality and suryivail in type 2 (non insulin dependent) diabetes mellitus. Diabetologia 1987;30:123-31
3. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987;3:463-542.
4. Stamler J, Vaccaro O, Neaton J, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
5. Head J, Fuller JH. International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 1990;33:477-81.
6. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. End-stage renal disease risk in diabetes mellitus. JAMA l997;278:1-8.
7. Shenvin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE. The Multiple Risk Factor Intervention Trial (MRFIT). II. The development of the protocol. Prev Med 1981;10:402-25.
8. Dischinger P, DuChene AG. Quality control aspects of blood pressure measurement in the Multiple Risk Factor Intervention Trial. Control Clin Trials 1986;6:137S-57S.
9. Department of Health Education and Welfare, Lipid Research Clinic Program (US). Manual of Operations, Vol. 1: Lipid and Lipoprotein Analysis. Washington, DC, US: Govt Printing Office, 1984.
10. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration MRB file and the National Death Index in the ascertainment of vital status. Am J Public Health 1983;73:1270-73.
11. International Classification of Diseases. Clinical Modification. 9th Revision, Vol. 1 Ann Arbor, MI: Edwards Bros, 1981.
12. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
14. Cooper R, Liu K, Stamler J et al. Prevalence of diabetes/hyperglycemia and associated cardiovascular risk factors in blacks and whites: Chicago Heart Association Detection Project in Industry. Am Heart J 1984;108:827-32.
15. Harris MI. Non insulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 1980;6;71-90.
16. Gillum RF, Grant CT. Coronary heart disease in black populations. II. Risk Factors. Am Heart J 1982:104:852-64.
17. Folsom AR, Gomez-Marin O, Sprafka MJ, Prineas RJ, Edlavitch SA, Gillum RF. Trends in cardiovascular risk factors in an urban black population, 1973-74 to 1985: The Minnesota Heart Survey. Am Heart J 1987;114:1199-205.
18. Harris MI. Hypercholesterolemia in diabetes and glucose intolerance in the US population. Diabetes Care 1991;14:366-74.
19. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988;128:389-401.
20. Lowe LP, Liu K, Greenland P, Metzger B, Dyer A, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 1997;20:163-69.
21. Gillum RF, Grant CT. Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J 1982;104:839-51.
22. Sortie PD, Backlund E, Keller JB. US mortality by economic, demographic, and social characteristics: the National Longitudinal Mortality Study. Am J Public Health 1995;85:949-56.
23. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: Part I - results for 300 685 White men. Am J Public Health 1996;86:486-96.
24. Davey Smith G, Wentworth D, Neaton JD, Stamler R, Stamler J. Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: Part II - results for 20 224 Black men. Am J Public Health 1996;86:497-504.
25. US Renal Data System. USRDS 1989 Annual Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1989.
26. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease -review of clinical and epidemiological evidence. Hypertension 1989;19(Suppl.I):I19-I27.
27. Walker WG, Neaton JD, Cutler JA, Neurwirth R, Cohen JD for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial, racial and treatment effect. JAMA 1992:268:3085-91.
28. Brancati FL, Klag MJ, Whelton PK, Randall BL, Neaton JD, Stamler J. End-stage renal disease in black and white diabetic men: a prospective cohort study (Abstract). Diabetes 1994;43:26A.
29. Watkins LO, Neaton JD, Kuller LH for the MRFIT Research Group. Racial differences in high density lipoprotein cholesterol and coronary heart disease incidence in the usual care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986;57:538-45.
30. Morrison JA, deGroot I, Kelly KA et al. Black-white differences in plasma lipids and lipoproteins in adults. The Cincinnati Lipid Research Clinics Princeton School Study. Prev Med 1979;8:34-39.
31. Summerson JH, Konen JC, Dignam MB. Racial differences in lipid and lipoprotein levels in diabetes. Metabolism 1992;41:851-55.
32. Vermark WJH, Ubbink JB, Delpon R, Beker PJ, Bissbort SH, Ungerer JPJ. Ethnic immunity to coronary heart disease. Atherosclerosis 1991;89:155-62.
33. Barnejj MA, Lebovitz HE. Coronary heart disease risk factor profiles in black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns. Am J Med 1991;91:51-58.
34. Chaiken RL, Barnejj MA, Pasmantier RM, Huey H, Hirsh S, Lebovitz HE. Pats of glucose and lipid abnormalities in black NIDDM subjects. Diabetes Care 1991;14:1036-42.
35. Chaiken RL, Barnejj MA, Huey H, Lebovitz HE. Do blacks with NIDDM have an insulin-resistant syndrome? Diabetes 1993;43:444-49.
36. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. The Atherosclerosis Risk in Communities Study Investigators. A metabolic syndrome in whites and African-Americans: The Atherosclerosis Risk in Communities baseline Study. Diabetes Care 1996;19:414-18.